Skip to main content
. 2016 May 24;14(1):705–714. doi: 10.3892/mmr.2016.5343

Table III.

Cell percentage following DHEA-treatment.

Group Cell cycle stage
6 h
12 h
24 h
48 h
G0/G1 (%) S (%) G2/M (%) G0/G1 (%) S (%) G2/M (%) G0/G1 (%) S (%) G2/M (%) G0/G1 (%) S (%) G2/M (%)
Vehicle 56.61±1.89 27.61±0.37 15.78±2.265 35.98±1.38 38.55±1.78 25.46±0.48 58.96±0.96 23.30±0.70 17.75±0.26 69.16±2.36 21.55±2.03 9.29±0.77
1 µmol/l DHEA 55.76±2.98 30.91±4.42 13.23±1.63 36.10±1.34 37.19±2.27 27.72±3.35 54.01±1.01 25.79±2.49 20.21±1.47 66.82±0.84 24.82±2.31 8.36±0.61
50 µmol/l DHEA 57.62±1.23 30.41±1.45 11.97±0.24 35.18±1.57 40.29±1.51 24.54±0.15 58.10±2.04 27.88±1.62 14.03±1.24 68.29±0.72 26.98±0.53b 4.73±0.66b
100 µmol/l DHEA 56.20±1.58 31.66±1.39 11.99±0.47 36.71±1.84 48.34±0.99b 14.95±1.72b 55.60±3.86 38.86±4.02b 5.55±1.03b 67.12±0.50 31.10±1.11b 1.78±0.29b

Cell cycle distribution was calculated from 10,000 cells with ModFit LTTM software using FACScaliber. Values are presented as the mean ± standard error (n=12).

a

P<0.05,

b

P<0.01 vs. vehicle group. DHEA, dehydroepiandrosterone.